Skip to main content

Sema4 to Participate in Upcoming Investor Conferences

Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate in fireside chats at two upcoming virtual investor conferences. Eric Schadt, PhD, Founder and Chief Executive Officer, and Isaac Ro, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 and the Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 8, 2021.

Event: Jefferies Virtual Healthcare Conference

Date: Friday, June 4, 2021

Time: 11:00 a.m. ET / 8:00 a.m. PT

Event: Goldman Sachs Annual Global Healthcare Conference

Date: Tuesday, June 8, 2021

Time: 1:20 p.m. ET / 10:20 a.m. PT

Following each conference, a Form 8-K with a copy of the transcript will be filed with the U.S. Securities and Exchange Commission (SEC). A link to the SEC filing will be available on the Company’s website at https://sema4.com/our-story/investors/.

About Sema4

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all. For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.